Li, Wennan <br/><br/>
Long-term spironolactone treatment reduces coronary TRPC expression, vasoconstriction, and atherosclerosis in metabolic syndrome pigs.  [electronic resource] 

 -  Basic research in cardiology  09 2017 
 - 54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1435-1803 
<br/><br/><label>Standard No.: </label>10.1007/s00395-017-0643-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Calcium Signaling--drug effects<br/>Cells, Cultured<br/>Coronary Artery Disease--genetics<br/>Coronary Vessels--drug effects<br/>Disease Models, Animal<br/>Down-Regulation<br/>Drug Administration Schedule<br/>Endothelium, Vascular--drug effects<br/>Macrophages--drug effects<br/>Metabolic Syndrome--drug therapy<br/>Mineralocorticoid Receptor Antagonists--administration & dosage<br/>Muscle, Smooth, Vascular--drug effects<br/>Spironolactone--administration & dosage<br/>Swine<br/>Swine, Miniature<br/>TRPC Cation Channels--drug effects<br/>TRPC6 Cation Channel--drug effects<br/>Time Factors<br/>Tissue Culture Techniques<br/>Vasoconstriction--drug effects